ORC6 and central nervous system cancer: Employing ORC6 silencing using shORC6-s1, shORC6-s2, or CRISPR/Cas9-mediated KO in P1 glioma cells, we observed a significant downregulation in the mRNA expression of these aforementioned genes (Fig. 7A).